Cardiac waiting lists continue to grow: Part II
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany In March we reported on the British Heart Foundation (BHF) response to NHS England’s figures demonstrating growing…
View More Cardiac waiting lists continue to grow: Part II
Imperial College Healthcare advertise new fellowship position
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany Imperial College Healthcare NHS Trust have advertised a new role open to both potential and current cardiology…
View More Imperial College Healthcare advertise new fellowship position
World Heart Federation: Key report released into worldwide cardiovascular health
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany The World Heart Federation recently published the World Heart Report. A challenging read, the report demonstrates how…
View More World Heart Federation: Key report released into worldwide cardiovascular health
Mapping the cardiac cellular environment: a route to novel therapeutics
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany The function of cells is dependent both on their intrinsic characteristics and niche; the microenvironment in which…
View More Mapping the cardiac cellular environment: a route to novel therapeutics
The power of cognition: Reducing AF symptom burden with cognitive behavioural therapy
By Dr Jonathan ShurlockEdited by Dr Saadia Aslam The symptomatic burden of atrial fibrillation (AF) is well documented, with a known impact on quality of…
View More The power of cognition: Reducing AF symptom burden with cognitive behavioural therapy
Chair vacancies on the Secretary of State for Transport’s Honorary Medical Advisory Panels
The DVLA has launched 4 new vacancies looking for a new Panel Chair for each of the Secretary of State for Transport’s Honorary Medical Advisory…
View More Chair vacancies on the Secretary of State for Transport’s Honorary Medical Advisory Panels
Apixaban is less effective than warfarin for On-X aortic valve
By Dr Timothy SwinnEdited by Dr Saadia Aslam The PROACT-Xa trial (Prospective Randomized On-X Anticoagulation Clinical Trial)1 was stopped early due to higher incidence of…
View More Apixaban is less effective than warfarin for On-X aortic valve
Worryingly low use of defibrillators at out of hospital cardiac arrests: Data from the Essex Cardiothoracic Centre
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany At the recent BCS annual conference, among the excellent collection of posters, one in particular was a…
View More Worryingly low use of defibrillators at out of hospital cardiac arrests: Data from the Essex Cardiothoracic Centre
TAVI benefits shown to be durable compared to surgery: The Evolut Low Risk trial
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany Transcatheter aortic valve implantation (TAVI) continues to be at the forefront of many discussions at present, particularly…
View More TAVI benefits shown to be durable compared to surgery: The Evolut Low Risk trial
Michael Davies Early Career Award: Professor Vanessa Ferreira
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany As part of the 2023 BCS annual conference, Professor Ferreira presented an overview of their research as…
View More Michael Davies Early Career Award: Professor Vanessa Ferreira